ULCERATIVE COLITIS
Clinical trials for ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Statins as gut microbiome modulators for ulcerative colitis: a failed promise?
Disease control TerminatedThis study tested whether statins, a common cholesterol drug, could change gut bacteria to reduce inflammation in people with ulcerative colitis. It included 177 adults with mild to moderate disease. The study was terminated early, so results are limited, but the idea was to see …
Matched conditions: ULCERATIVE COLITIS
Phase: PHASE2, PHASE3 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated May 01, 2026 15:43 UTC
-
Ulcerative colitis biosimilar trial halted early
Disease control TerminatedThis study tested whether AVT16, a biosimilar, works as well as the approved drug Entyvio for people with moderate to severe ulcerative colitis. About 301 adults aged 18 to 80 took part. The trial was terminated early, so results are limited.
Matched conditions: ULCERATIVE COLITIS
Phase: PHASE3 • Sponsor: Alvotech Swiss AG • Aim: Disease control
Last updated May 01, 2026 15:41 UTC
-
Real-World study examines Tofacitinib's effect on ulcerative colitis
Disease control TerminatedThis study aimed to see how well the drug tofacitinib works for people with moderate to severe ulcerative colitis in everyday medical practice in Switzerland. Researchers tracked symptoms and a marker of gut inflammation in 18 adults over 8 weeks. The study was terminated early, …
Matched conditions: ULCERATIVE COLITIS
Sponsor: Pfizer • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC